- Home
- TOP vs CASI Comparison
TOP vs CASI Comparison
Compare TOP & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOP
- CASI
- Stock Information
- Founded
- TOP 2015
- CASI 1991
- Country
- TOP Hong Kong
- CASI China
- Employees
- TOP N/A
- CASI N/A
- Industry
- TOP Investment Bankers/Brokers/Service
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- TOP Finance
- CASI Health Care
- Exchange
- TOP Nasdaq
- CASI Nasdaq
- Market Cap
- TOP 57.8M
- CASI 58.8M
- IPO Year
- TOP 2022
- CASI 1996
- Fundamental
- Price
- TOP $1.47
- CASI $2.62
- Analyst Decision
- TOP
- CASI Strong Buy
- Analyst Count
- TOP 0
- CASI 1
- Target Price
- TOP N/A
- CASI $6.00
- AVG Volume (30 Days)
- TOP 195.0K
- CASI 42.2K
- Earning Date
- TOP 01-29-2025
- CASI 11-15-2024
- Dividend Yield
- TOP N/A
- CASI N/A
- EPS Growth
- TOP N/A
- CASI N/A
- EPS
- TOP 0.03
- CASI N/A
- Revenue
- TOP $8,037,105.00
- CASI $22,055,000.00
- Revenue This Year
- TOP N/A
- CASI N/A
- Revenue Next Year
- TOP N/A
- CASI $134.79
- P/E Ratio
- TOP $45.12
- CASI N/A
- Revenue Growth
- TOP N/A
- CASI N/A
- 52 Week Low
- TOP $1.25
- CASI $2.05
- 52 Week High
- TOP $7.77
- CASI $8.19
- Technical
- Relative Strength Index (RSI)
- TOP 47.79
- CASI 38.56
- Support Level
- TOP $1.35
- CASI $2.44
- Resistance Level
- TOP $1.50
- CASI $2.76
- Average True Range (ATR)
- TOP 0.12
- CASI 0.29
- MACD
- TOP 0.00
- CASI 0.03
- Stochastic Oscillator
- TOP 42.50
- CASI 21.18
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.